Chemoinformaics analysis of 4,21-Dehydrocorynantheine aldehyde
Molecular Weight | 351.426 | nRot | 3 |
Heavy Atom Molecular Weight | 328.242 | nRig | 23 |
Exact Molecular Weight | 351.17 | nRing | 4 |
Solubility: LogS | -3.834 | nHRing | 3 |
Solubility: LogP | 2.761 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
nHA | 3 | APOL | 55.0122 |
nHD | 2 | BPOL | 27.9578 |
QED | 0.303 |
Synth | 4.765 |
Natural Product Likeliness | 1.21 |
NR-PPAR-gamma | 0.113 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.346 |
HIA | 0.087 |
CACO-2 | -4.777 |
MDCK | 0.0000235 |
BBB | 0.221 |
PPB | 0.647534 |
VDSS | 1.727 |
FU | 0.239423 |
CYP1A2-inh | 0.162 |
CYP1A2-sub | 0.813 |
CYP2c19-inh | 0.061 |
CYP2c19-sub | 0.4 |
CYP2c9-inh | 0.024 |
CYP2c9-sub | 0.137 |
CYP2d6-inh | 0.021 |
CYP2d6-sub | 0.495 |
CYP3a4-inh | 0.928 |
CYP3a4-sub | 0.505 |
CL | 2.619 |
T12 | 0.356 |
hERG | 0.064 |
Ames | 0.018 |
ROA | 0.466 |
SkinSen | 0.75 |
Carcinogencity | 0.126 |
EI | 0.017 |
Respiratory | 0.943 |
NR-Aromatase | 0.119 |
Antiviral | Yes |
Prediction | 0.584074 |